Last $2.12 USD
Change Today -0.05 / -2.30%
Volume 17.2K
GNVC On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 12:24 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Wayne T. Hockmeyer Ph.D.

Chairman of The Board, Chairman of Compensation Committee and Member of Nominating and Corporate Governance Committee, GenVec, Inc.
AgeTotal Calculated CompensationThis person is connected to 41 board members in 5 different organizations across 14 different industries.

See Board Relationships
69$108,450

Background*

Dr. Wayne T. Hockmeyer, Ph.D., served as the President of MedImmune Ventures Inc., a wholly-owned subsidiary of MedImmune Inc. from 2002 to June 1, 2007. Dr. Hockmeyer founded MedImmune, Inc. in April 1988 and served as its President and Chief Executive Officer from April 1988 to October 2000. From 1986 to 1988, he served as a Vice President of Research and Development at Praxis Biologics Inc. He was also employed at QIAGEN Gaithersburg, Inc. He has been Chairman of ...

Read Full Background

Corporate Headquarters*

910 Clopper Road
Gaithersburg, Maryland 20878

United States

Phone: 240-632-0740
Fax: 240-632-0735

Board Members Memberships*

Director
Former Director
Director
1988-2007
Founder
2000-Present
Director
2000-Present
Chairman of The Board, Chairman of Compensation Committee and Member of Nominating and Corporate Governance Committee
2000-N/A
Former Director
2000-2009
Former Lead Independent Director, Chairman of Compensation Committee and Member of Executive Committee
2001-2004
Former Director
2001-Present
Chairman, Member of Audit Committee, Member of Nominating Committee and Member of Corporate Governance Committee
2002-2014
Former Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
2003-2005
Former Director, Member of Audit Committee and Member of Compensation Committee
2004-2006
Former Director
2006-N/A
Former Director
2006-N/A
Director
2007-Present
Director, Chairman of Science & Technology Committee and Member of Finance Committee

Education*

ScD 2002
Purdue University
BS 1966
Purdue University
PhD 1972
University of Florida

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options27,000
Unexercisable Options75,000
Total Number of Options102,000

Total Compensation*

Total Annual Cash Compensation$88,500
Total Calculated Compensation$108,450
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNVC:US $2.12 USD -0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey D. Abbey MBA, J.D.Chief Executive Officer, President and Director
Argos Therapeutics, Inc.
$436.8K
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$557.0K
Hans Arwidsson Ph.D.Chief Executive Officer and President
Eurocine Vaccines AB
--
Daniel J. O’Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$312.5K
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$334.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENVEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.